13) ANCILLARY REVIEWS: Please review the following sections to determine if any ancillary reviews are required. If so, for any ancillary reviewer other than IBC, please share the IRBNet submission with the ancillary reviewer. Although the IRB may grant a approval” of the research “conditional when ancillary review is required, the research CANNOT begin until the IRB has granted final IRB approval. UHB Pathology Laboratories: the box below to indicate whether the research involves any of the following: At least one box MUST be checked. (13a1) Services or assistance of the UHB Pathology Laboratories (Clinical Laboratory, Histology Lab and/or Surgical Pathology). (13a2) Prospective collection of fresh specimens that require processing by UHB Pathology Laboratories, including tissue, blood and fluids (see UHB Exempt Tissue Policy: Human Tissue Fluid and Foreign Matter Exempt From Submission for Pathology “LAB3 Examination”, which may be viewed or downloaded at: ) (13a3) None of the above. UHB Pathology Laboratories ancillary review is not required. If uncertain about the need for Pathology Review, please email Susan Gottesman & Caitlin Otto for a determination. If they state Pathology Ancillary review is not required, attach the e-mail determination to the IRB submission. If box or is checked please do the following: “13a1” “13a2” Step 1: to the UHB Pathology Instructions, Forms, and Fees posted in IRBNet/IRB Website. Note: These will be posted on the Pathology website in the near future and removed from the IRB website. Complete and submit 1 Form: Preparation for Use of UHB Laboratory/Patient specimens for Research Projects: Clinical, “Step Histology, and Surgical Pathology Labs Feasibility Determination” to Pathology. Step 2: Complete and submit the IRB application after the UHB Pathology Laboratories approves the feasibility of using their services to obtain IRB approval.
13) ANCILLARY REVIEWS: Please review the following sections to determine if any ancillary reviews are required. If so, for any ancillary reviewer other than IBC, please share the IRBNet submission with the ancillary reviewer. Although the IRB may grant a “conditional approval” of the research when ancillary review is required, the research CANNOT begin until the IRB has granted final IRB approval. UHB Pathology Laboratories: the box below to indicate whether the research involves any of the following: At least one box MUST be checked. (13a1) Services or assistance of the UHB Pathology Laboratories (Clinical Laboratory, Histology Lab and/or Surgical Pathology). (13a2) Prospective collection of fresh specimens that require processing by UHB Pathology Laboratories, including tissue, blood and fluids (see UHB Exempt Tissue Policy: “LAB3 Human Tissue Fluid and Foreign Matter Exempt From Submission for Pathology Examination”, which may be viewed or downloaded at: ) (13a3) None of the above. UHB Pathology Laboratories ancillary review is not required. If uncertain about the need for Pathology Review, please email Susan Gottesman & Caitlin Otto for a determination. If they state Pathology Ancillary review is not required, attach the e-mail determination to the IRB submission. If box “13a1” or “13a2” is checked please do the following: Step 1: to the UHB Pathology Instructions, Forms, and Fees posted in IRBNet/IRB Website. Note: These will be posted on the Pathology website in the near future and removed from the IRB website. Complete and submit “Step 1 Form: Preparation for Use of UHB Laboratory/Patient specimens for Research Projects: Clinical, Histology, and Surgical Pathology Labs Feasibility Determination” to Pathology. Step 2: Complete and submit the IRB application after the UHB Pathology Laboratories approves the feasibility of using their services to obtain IRB approval.